Radium Ra 223 Dichloride Therapy in the Private Practice Environment.
作者信息
Seeber Jeffrey C
机构信息
A.M.P. Radiation Oncology Syracuse, NY.
出版信息
Rev Urol. 2016;18(2):106-9. doi: 10.3909/riu0720.
Abstract
摘要
相似文献
1
Radium Ra 223 Dichloride Therapy in the Private Practice Environment.私人执业环境下的二氯化镭 Ra 223 疗法
Rev Urol. 2016;18(2):106-9. doi: 10.3909/riu0720.
2
Radium Ra 223 dichloride in castration-resistant prostate cancer.二氯化镭 Ra 223 用于去势抵抗性前列腺癌
Drugs Today (Barc). 2013 Aug;49(8):483-90. doi: 10.1358/dot.2013.49.8.1968670.
3
Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice.镭-二氯化物在去势抵抗性转移性前列腺癌中的应用：改善临床实践中的结局并识别生存预测因素。
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2264-2273. doi: 10.1007/s00259-018-4083-3. Epub 2018 Jul 11.
4
Radium-223 dichloride: a novel treatment option for castration-resistant prostate cancer patients with symptomatic bone metastases.二氯化镭-223：一种用于有症状骨转移的去势抵抗性前列腺癌患者的新型治疗选择。
Ann Pharmacother. 2015 Apr;49(4):469-76. doi: 10.1177/1060028014565444. Epub 2015 Jan 8.
5
Impact of pre-treatment variables on the completion of radium-dichloride therapy in mCRPC patients with bone metastases.预处理变量对伴有骨转移的mCRPC患者二氯化镭治疗完成情况的影响。
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:153-163.
6
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.发射α粒子的二氯化镭（²²³Ra）靶向放射性核素治疗中骨转移灶的剂量测定
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):21-33. doi: 10.1007/s00259-015-3150-2. Epub 2015 Aug 13.
7
A unique drug distribution process for radium Ra 223 dichloride injection and its implication for product quality, patient privacy, and delineation of professional responsibilities.二氯化镭Ra 223注射液独特的药物配送流程及其对产品质量、患者隐私和专业职责界定的影响。
Ann Pharmacother. 2014 Nov;48(11):1512-4. doi: 10.1177/1060028014545644.
8
Retrospective Toxicological Profiling of Radium-223 Dichloride for the Treatment of Bone Metastases in Prostate Cancer Using Adverse Event Data.回顾性毒理学分析镭-223 二氯化物治疗前列腺癌骨转移的安全性：基于不良事件数据。
Medicina (Kaunas). 2019 May 16;55(5):149. doi: 10.3390/medicina55050149.
9
Compartmental Model for Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.放射性氯化镭在去势抵抗性前列腺癌骨转移患者中的房室模型。
Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):884-892. doi: 10.1016/j.ijrobp.2019.07.022. Epub 2019 Jul 23.
10
Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.镭 223 二氯化物注射液：美国食品药品监督管理局药物批准摘要。
Clin Cancer Res. 2014 Jan 1;20(1):9-14. doi: 10.1158/1078-0432.CCR-13-2665. Epub 2013 Nov 4.
引用本文的文献
1
Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.镭-223治疗转移性前列腺癌的不良事件：对反映全球使用情况的FDA数据进行的不成比例分析
Clin Genitourin Cancer. 2020 Jun;18(3):192-200.e2. doi: 10.1016/j.clgc.2019.11.017. Epub 2019 Dec 5.
2
Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice.成功将二氯化镭Ra 223注射液纳入泌尿外科临床实践。
Rev Urol. 2017;19(4):248-251. doi: 10.3909/riu0782.
Zotero 插件